Patents by Inventor Walker R. Force

Walker R. Force has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100234578
    Abstract: An antibody or a functional fragment thereof, acting agonistically or antagonistically on CD40.
    Type: Application
    Filed: March 23, 2010
    Publication date: September 16, 2010
    Applicant: KYOWA HAKKO KIRIN CO., LTD.
    Inventors: Toshifumi Mikayama, Hitoshi Yoshida, Walker R. Force, Xingjie Chen, Nobuaki Takahashi
  • Patent number: 7537763
    Abstract: An antibody or a functional fragment thereof, acting agonistically or antagonistically on CD40.
    Type: Grant
    Filed: December 5, 2006
    Date of Patent: May 26, 2009
    Assignee: Kyowa Hakko Kirin Co., Ltd.
    Inventors: Toshifumi Mikayama, Hitoshi Yoshida, Walker R. Force, Xingjie Chen, Nobuaki Takahashi
  • Publication number: 20090123466
    Abstract: An antibody or a functional fragment thereof, acting agonistically or antagonistically on CD40.
    Type: Application
    Filed: October 6, 2008
    Publication date: May 14, 2009
    Inventors: TOSHIFUMI MIKAYAMA, Hitoshi Yoshida, Walker R. Force, Xingjie Chen, Nobuaki Takahashi
  • Patent number: 7193064
    Abstract: An antibody or a functional fragment thereof, acting agonistically or antagonistically on CD40.
    Type: Grant
    Filed: October 23, 2003
    Date of Patent: March 20, 2007
    Assignee: Kirin Beer Kabushiki Kaisha
    Inventors: Toshifumi Mikayama, Hitoshi Yoshida, Walker R. Force, Xingjie Chen, Nobuaki Takahashi
  • Publication number: 20040120948
    Abstract: An antibody or a functional fragment thereof, acting agonistically or antagonistically on CD40.
    Type: Application
    Filed: October 23, 2003
    Publication date: June 24, 2004
    Inventors: Toshifumi Mikayama, Hitoshi Yoshida, Walker R. Force, Xingjie Chen, Nobuaki Takahashi
  • Publication number: 20030059427
    Abstract: The invention is directed to human agonistic and antagonistic antibodies that bind CD40 (e.g., human CD40), methods of producing the antibodies and methods of use. Invention human CD40 antibodies include antibodies that can stimulate or inhibit one or more activities of CD40, such as increasing or decreasing cell proliferation. Invention human CD40 antibodies are therefore useful for increasing or decreasing a CD40 activity in order to alter CD40 activity in vivo.
    Type: Application
    Filed: October 26, 2001
    Publication date: March 27, 2003
    Inventors: Walker R. Force, Nobuaki Takahashi, Toshifumi Mikayama